[Form 4] Stride, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Stride, Inc. (LRN) reporting person James Jeaho Rhyu, who is the company's Chief Executive Officer and a director, recorded two equity transactions in August 2025. On 08/18/2025 the filing shows 9,282 restricted shares were withheld to satisfy the reporting person’s tax withholding obligations upon vesting at a price of $162.63, leaving 720,314 shares beneficially owned. On 08/19/2025 the filing reports sales of 13,961 shares under a Rule 10b5-1 plan (adopted 12/02/2024) at a weighted average price of $162.66, leaving 706,353 shares outstanding for the reporting person.

Positive

• Transactions were disclosed promptly on Form 4, satisfying Section 16 reporting requirements
• Sales were executed under a documented Rule 10b5-1 plan (adopted 12/02/2024), providing procedural transparency
• Withholding to cover taxes on vested restricted shares is explicitly disclosed, including the mechanics tied to closing prices

Negative

• Insider sales reduced beneficial ownership from 720,314 to 706,353 shares, showing a net decrease in holdings
• Sales occurred at market prices (weighted average $162.66) which may be viewed negatively by some investors, though no intent is stated

Insights

Securities Analyst

TL;DR: Insider tax-withholding and Rule 10b5-1 sales reduced CEO holdings modestly; transactions were disclosed and documented.

The Form 4 discloses routine corporate share-withholding to satisfy tax obligations upon vesting and subsequent sales executed under a pre-established 10b5-1 trading plan. The withholding transaction (9,282 shares) and the sales (13,961 shares at a weighted average $162.66) are explicitly recorded with resulting beneficial ownership counts. From an investor disclosure perspective, the filing meets Section 16 requirements and includes the 10b5-1 adoption date and price range for the sales.

Corporate Governance Expert

TL;DR: Insider followed a documented plan and reported withholding; disclosure is timely and includes required explanatory footnotes.

The reporting person is identified as both CEO and director and the filing notes the use of a Rule 10b5-1 plan adopted 12/02/2024, which supports an affirmative defense for the sales. The explanatory footnotes specify the withholding methodology and the weighted-average price range for the sales, indicating clear internal recordkeeping and compliance with reporting obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rhyu James Jeaho

(Last) (First) (Middle)

11720 PLAZA AMERICA DRIVE

9TH FLOOR

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Stride, Inc. [ LRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		F(1)		9,282	D	$162.63	720,314	D
Common Stock	08/19/2025		S(2)		13,961	D	$162.66(3)	706,353	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares withheld by the Company upon the vesting of restricted shares to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Stride common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Stride common stock on the most recent prior market day.

2. The sales reported in these transactions were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 2, 2024.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.68 to $163.91, inclusive. The reporting person undertakes to provide to Stride, Inc., any security holder of Stride, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ John C. Grothaus, Attorney-in-fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Stride (LRN) report by James Jeaho Rhyu?

The Form 4 shows 9,282 shares withheld for tax upon vesting on 08/18/2025 at $162.63 and 13,961 shares sold on 08/19/2025 at a weighted average price of $162.66.

Were the sales by the Stride CEO part of a trading plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 plan adopted on 12/02/2024.

How many Stride shares does the reporting person own after these transactions?

Following the transactions the reporting person beneficially owned 706,353 shares according to the Form 4.

What prices were reported for the sales in the Form 4?

The withholding used a closing price of $162.63; the sales on 08/19/2025 had a weighted average price of $162.66 (individual trades ranged $161.68–$163.91).

Does the Form 4 explain the withholding and sale mechanics?

Yes. Footnotes explain that withheld shares covered tax withholding on vesting and that sales were under a 10b5-1 plan, with the weighted-average price and range disclosed.